 | • レポートコード：MRC2-11QY03979 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は次世代シーケンシング（NGS）のグローバル市場について調査・分析したレポートです。種類別（消耗品、プラットフォーム、サービス）市場規模、用途別（学術・政府研究所、製薬会社、バイオテクノロジー会社、病院＆クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別次世代シーケンシング（NGS）の競争状況、市場シェア ・世界の次世代シーケンシング（NGS）市場：種類別市場規模 2015年-2020年（消耗品、プラットフォーム、サービス） ・世界の次世代シーケンシング（NGS）市場：種類別市場規模予測 2021年-2026年（消耗品、プラットフォーム、サービス） ・世界の次世代シーケンシング（NGS）市場：用途別市場規模 2015年-2020年（学術・政府研究所、製薬会社、バイオテクノロジー会社、病院＆クリニック） ・世界の次世代シーケンシング（NGS）市場：用途別市場規模予測 2021年-2026年（学術・政府研究所、製薬会社、バイオテクノロジー会社、病院＆クリニック） ・北米の次世代シーケンシング（NGS）市場分析：米国、カナダ ・ヨーロッパの次世代シーケンシング（NGS）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの次世代シーケンシング（NGS）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の次世代シーケンシング（NGS）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの次世代シーケンシング（NGS）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Illumina、Thermo Fisher Scientific、Pacific Biosciences of California、Beijing Genomics Institute、Qiagen、Roche、Agilent Technologies、Perkinelmer、Genomatix、PierianDx、Eurofins Scientific、Gatc Biotech、Oxford Nanopore Technologies、Bio-Rad Laboratories、DNASTAR、Biomatters、Partek、New England Biolabs、Myriad Genetics、Macrogen、GATC Biotech ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing.
The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud computing in NGS for data management and untapped emerging economies are expected to provide new market opportunities to NGS manufacturers in the near future.
Market Analysis and Insights: Global Next Generation Sequencing (NGS) Market
The global Next Generation Sequencing (NGS) market size is projected to reach US$ 5156.7 million by 2026, from US$ 4745.6 million in 2020, at a CAGR of 8.0%% during 2021-2026.
Global Next Generation Sequencing (NGS) Scope and Market Size
Next Generation Sequencing (NGS) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Sequencing (NGS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics
Macrogen
GATC Biotech
Market segment by Type, the product can be split into
Consumables
Platforms
Services
Market segment by Application, split into
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Revenue
1.4 Market by Type
1.4.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Consumables
1.4.3 Platforms
1.4.4 Services
1.5 Market by Application
1.5.1 Global Next Generation Sequencing (NGS) Market Share by Application: 2020 VS 2026
1.5.2 Academic & Government Research Institutes
1.5.3 Pharmaceutical Companies
1.5.4 Biotechnology Companies
1.5.5 Hospitals & Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing (NGS) Market Perspective (2015-2026)
2.2 Global Next Generation Sequencing (NGS) Growth Trends by Regions
2.2.1 Next Generation Sequencing (NGS) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Next Generation Sequencing (NGS) Historic Market Share by Regions (2015-2020)
2.2.3 Next Generation Sequencing (NGS) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Next Generation Sequencing (NGS) Market Growth Strategy
2.3.6 Primary Interviews with Key Next Generation Sequencing (NGS) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing (NGS) Players by Market Size
3.1.1 Global Top Next Generation Sequencing (NGS) Players by Revenue (2015-2020)
3.1.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Players (2015-2020)
3.1.3 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Next Generation Sequencing (NGS) Market Concentration Ratio
3.2.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2019
3.3 Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.4 Key Players Next Generation Sequencing (NGS) Product Solution and Service
3.5 Date of Enter into Next Generation Sequencing (NGS) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Next Generation Sequencing (NGS) Historic Market Size by Type (2015-2020)
4.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Next Generation Sequencing (NGS) Market Size (2015-2020)
6.2 Next Generation Sequencing (NGS) Key Players in North America (2019-2020)
6.3 North America Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
6.4 North America Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Next Generation Sequencing (NGS) Market Size (2015-2020)
7.2 Next Generation Sequencing (NGS) Key Players in Europe (2019-2020)
7.3 Europe Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
7.4 Europe Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
8 China
8.1 China Next Generation Sequencing (NGS) Market Size (2015-2020)
8.2 Next Generation Sequencing (NGS) Key Players in China (2019-2020)
8.3 China Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
8.4 China Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Next Generation Sequencing (NGS) Market Size (2015-2020)
9.2 Next Generation Sequencing (NGS) Key Players in Japan (2019-2020)
9.3 Japan Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
9.4 Japan Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Next Generation Sequencing (NGS) Market Size (2015-2020)
10.2 Next Generation Sequencing (NGS) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
10.4 Southeast Asia Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
11 India
11.1 India Next Generation Sequencing (NGS) Market Size (2015-2020)
11.2 Next Generation Sequencing (NGS) Key Players in India (2019-2020)
11.3 India Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
11.4 India Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Next Generation Sequencing (NGS) Market Size (2015-2020)
12.2 Next Generation Sequencing (NGS) Key Players in Central & South America (2019-2020)
12.3 Central & South America Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
12.4 Central & South America Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview
13.1.3 Illumina Next Generation Sequencing (NGS) Introduction
13.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Details
13.2.2 Thermo Fisher Scientific Business Overview
13.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Introduction
13.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.2.5 Thermo Fisher Scientific Recent Development
13.3 Pacific Biosciences of California
13.3.1 Pacific Biosciences of California Company Details
13.3.2 Pacific Biosciences of California Business Overview
13.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Introduction
13.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.3.5 Pacific Biosciences of California Recent Development
13.4 Beijing Genomics Institute
13.4.1 Beijing Genomics Institute Company Details
13.4.2 Beijing Genomics Institute Business Overview
13.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Introduction
13.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.4.5 Beijing Genomics Institute Recent Development
13.5 Qiagen
13.5.1 Qiagen Company Details
13.5.2 Qiagen Business Overview
13.5.3 Qiagen Next Generation Sequencing (NGS) Introduction
13.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.5.5 Qiagen Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Next Generation Sequencing (NGS) Introduction
13.6.4 Roche Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Agilent Technologies
13.7.1 Agilent Technologies Company Details
13.7.2 Agilent Technologies Business Overview
13.7.3 Agilent Technologies Next Generation Sequencing (NGS) Introduction
13.7.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.7.5 Agilent Technologies Recent Development
13.8 Perkinelmer
13.8.1 Perkinelmer Company Details
13.8.2 Perkinelmer Business Overview
13.8.3 Perkinelmer Next Generation Sequencing (NGS) Introduction
13.8.4 Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.8.5 Perkinelmer Recent Development
13.9 Genomatix
13.9.1 Genomatix Company Details
13.9.2 Genomatix Business Overview
13.9.3 Genomatix Next Generation Sequencing (NGS) Introduction
13.9.4 Genomatix Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.9.5 Genomatix Recent Development
13.10 PierianDx
13.10.1 PierianDx Company Details
13.10.2 PierianDx Business Overview
13.10.3 PierianDx Next Generation Sequencing (NGS) Introduction
13.10.4 PierianDx Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
13.10.5 PierianDx Recent Development
13.11 Eurofins Scientific
10.11.1 Eurofins Scientific Company Details
10.11.2 Eurofins Scientific Business Overview
10.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Introduction
10.11.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.11.5 Eurofins Scientific Recent Development
13.12 Gatc Biotech
10.12.1 Gatc Biotech Company Details
10.12.2 Gatc Biotech Business Overview
10.12.3 Gatc Biotech Next Generation Sequencing (NGS) Introduction
10.12.4 Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.12.5 Gatc Biotech Recent Development
13.13 Oxford Nanopore Technologies
10.13.1 Oxford Nanopore Technologies Company Details
10.13.2 Oxford Nanopore Technologies Business Overview
10.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Introduction
10.13.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.13.5 Oxford Nanopore Technologies Recent Development
13.14 Bio-Rad Laboratories
10.14.1 Bio-Rad Laboratories Company Details
10.14.2 Bio-Rad Laboratories Business Overview
10.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Introduction
10.14.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.14.5 Bio-Rad Laboratories Recent Development
13.15 DNASTAR
10.15.1 DNASTAR Company Details
10.15.2 DNASTAR Business Overview
10.15.3 DNASTAR Next Generation Sequencing (NGS) Introduction
10.15.4 DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.15.5 DNASTAR Recent Development
13.16 Biomatters
10.16.1 Biomatters Company Details
10.16.2 Biomatters Business Overview
10.16.3 Biomatters Next Generation Sequencing (NGS) Introduction
10.16.4 Biomatters Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.16.5 Biomatters Recent Development
13.17 Partek
10.17.1 Partek Company Details
10.17.2 Partek Business Overview
10.17.3 Partek Next Generation Sequencing (NGS) Introduction
10.17.4 Partek Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.17.5 Partek Recent Development
13.18 New England Biolabs
10.18.1 New England Biolabs Company Details
10.18.2 New England Biolabs Business Overview
10.18.3 New England Biolabs Next Generation Sequencing (NGS) Introduction
10.18.4 New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.18.5 New England Biolabs Recent Development
13.19 Myriad Genetics
10.19.1 Myriad Genetics Company Details
10.19.2 Myriad Genetics Business Overview
10.19.3 Myriad Genetics Next Generation Sequencing (NGS) Introduction
10.19.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.19.5 Myriad Genetics Recent Development
13.20 Macrogen
10.20.1 Macrogen Company Details
10.20.2 Macrogen Business Overview
10.20.3 Macrogen Next Generation Sequencing (NGS) Introduction
10.20.4 Macrogen Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.20.5 Macrogen Recent Development
13.21 GATC Biotech
10.21.1 GATC Biotech Company Details
10.21.2 GATC Biotech Business Overview
10.21.3 GATC Biotech Next Generation Sequencing (NGS) Introduction
10.21.4 GATC Biotech Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
10.21.5 GATC Biotech Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Next Generation Sequencing (NGS) Key Market Segments
Table 2. Key Players Covered: Ranking by Next Generation Sequencing (NGS) Revenue
Table 3. Ranking of Global Top Next Generation Sequencing (NGS) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Consumables
Table 6. Key Players of Platforms
Table 7. Key Players of Services
Table 8. Global Next Generation Sequencing (NGS) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Next Generation Sequencing (NGS) Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Next Generation Sequencing (NGS) Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Next Generation Sequencing (NGS) Market Share by Regions (2015-2020)
Table 12. Global Next Generation Sequencing (NGS) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Next Generation Sequencing (NGS) Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Next Generation Sequencing (NGS) Market Growth Strategy
Table 18. Main Points Interviewed from Key Next Generation Sequencing (NGS) Players
Table 19. Global Next Generation Sequencing (NGS) Revenue by Players (2015-2020) (Million US$)
Table 20. Global Next Generation Sequencing (NGS) Market Share by Players (2015-2020)
Table 21. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Sequencing (NGS) as of 2019)
Table 22. Global Next Generation Sequencing (NGS) by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Next Generation Sequencing (NGS) Product Solution and Service
Table 25. Date of Enter into Next Generation Sequencing (NGS) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Next Generation Sequencing (NGS) Market Size by Type (2015-2020) (Million US$)
Table 28. Global Next Generation Sequencing (NGS) Market Size Share by Type (2015-2020)
Table 29. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2021-2026)
Table 30. Global Next Generation Sequencing (NGS) Market Size Share by Application (2015-2020)
Table 31. Global Next Generation Sequencing (NGS) Market Size by Application (2015-2020) (Million US$)
Table 32. Global Next Generation Sequencing (NGS) Market Size Share by Application (2021-2026)
Table 33. North America Key Players Next Generation Sequencing (NGS) Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Next Generation Sequencing (NGS) Market Share (2019-2020)
Table 35. North America Next Generation Sequencing (NGS) Market Size by Type (2015-2020) (Million US$)
Table 36. North America Next Generation Sequencing (NGS) Market Share by Type (2015-2020)
Table 37. North America Next Generation Sequencing (NGS) Market Size by Application (2015-2020) (Million US$)
Table 38. North America Next Generation Sequencing (NGS) Market Share by Application (2015-2020)
Table 39. Europe Key Players Next Generation Sequencing (NGS) Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Next Generation Sequencing (NGS) Market Share (2019-2020)
Table 41. Europe Next Generation Sequencing (NGS) Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Next Generation Sequencing (NGS) Market Share by Type (2015-2020)
Table 43. Europe Next Generation Sequencing (NGS) Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Next Generation Sequencing (NGS) Market Share by Application (2015-2020)
Table 45. China Key Players Next Generation Sequencing (NGS) Revenue (2019-2020) (Million US$)
Table 46. China Key Players Next Generation Sequencing (NGS) Market Share (2019-2020)
Table 47. China Next Generation Sequencing (NGS) Market Size by Type (2015-2020) (Million US$)
Table 48. China Next Generation Sequencing (NGS) Market Share by Type (2015-2020)
Table 49. China Next Generation Sequencing (NGS) Market Size by Application (2015-2020) (Million US$)
Table 50. China Next Generation Sequencing (NGS) Market Share by Application (2015-2020)
Table 51. Japan Key Players Next Generation Sequencing (NGS) Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Next Generation Sequencing (NGS) Market Share (2019-2020)
Table 53. Japan Next Generation Sequencing (NGS) Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Next Generation Sequencing (NGS) Market Share by Type (2015-2020)
Table 55. Japan Next Generation Sequencing (NGS) Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Next Generation Sequencing (NGS) Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Next Generation Sequencing (NGS) Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Next Generation Sequencing (NGS) Market Share (2019-2020)
Table 59. Southeast Asia Next Generation Sequencing (NGS) Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Next Generation Sequencing (NGS) Market Share by Type (2015-2020)
Table 61. Southeast Asia Next Generation Sequencing (NGS) Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Next Generation Sequencing (NGS) Market Share by Application (2015-2020)
Table 63. India Key Players Next Generation Sequencing (NGS) Revenue (2019-2020) (Million US$)
Table 64. India Key Players Next Generation Sequencing (NGS) Market Share (2019-2020)
Table 65. India Next Generation Sequencing (NGS) Market Size by Type (2015-2020) (Million US$)
Table 66. India Next Generation Sequencing (NGS) Market Share by Type (2015-2020)
Table 67. India Next Generation Sequencing (NGS) Market Size by Application (2015-2020) (Million US$)
Table 68. India Next Generation Sequencing (NGS) Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Next Generation Sequencing (NGS) Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Next Generation Sequencing (NGS) Market Share (2019-2020)
Table 71. Central & South America Next Generation Sequencing (NGS) Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Next Generation Sequencing (NGS) Market Share by Type (2015-2020)
Table 73. Central & South America Next Generation Sequencing (NGS) Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Next Generation Sequencing (NGS) Market Share by Application (2015-2020)
Table 75. Illumina Company Details
Table 76. Illumina Business Overview
Table 77. Illumina Product
Table 78. Illumina Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 79. Illumina Recent Development
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Product
Table 83. Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 84. Thermo Fisher Scientific Recent Development
Table 85. Pacific Biosciences of California Company Details
Table 86. Pacific Biosciences of California Business Overview
Table 87. Pacific Biosciences of California Product
Table 88. Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 89. Pacific Biosciences of California Recent Development
Table 90. Beijing Genomics Institute Company Details
Table 91. Beijing Genomics Institute Business Overview
Table 92. Beijing Genomics Institute Product
Table 93. Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 94. Beijing Genomics Institute Recent Development
Table 95. Qiagen Company Details
Table 96. Qiagen Business Overview
Table 97. Qiagen Product
Table 98. Qiagen Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 99. Qiagen Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Product
Table 103. Roche Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 104. Roche Recent Development
Table 105. Agilent Technologies Company Details
Table 106. Agilent Technologies Business Overview
Table 107. Agilent Technologies Product
Table 108. Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 109. Agilent Technologies Recent Development
Table 110. Perkinelmer Business Overview
Table 111. Perkinelmer Product
Table 112. Perkinelmer Company Details
Table 113. Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 114. Perkinelmer Recent Development
Table 115. Genomatix Company Details
Table 116. Genomatix Business Overview
Table 117. Genomatix Product
Table 118. Genomatix Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 119. Genomatix Recent Development
Table 120. PierianDx Company Details
Table 121. PierianDx Business Overview
Table 122. PierianDx Product
Table 123. PierianDx Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 124. PierianDx Recent Development
Table 125. Eurofins Scientific Company Details
Table 126. Eurofins Scientific Business Overview
Table 127. Eurofins Scientific Product
Table 128. Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 129. Eurofins Scientific Recent Development
Table 130. Gatc Biotech Company Details
Table 131. Gatc Biotech Business Overview
Table 132. Gatc Biotech Product
Table 133. Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 134. Gatc Biotech Recent Development
Table 135. Oxford Nanopore Technologies Company Details
Table 136. Oxford Nanopore Technologies Business Overview
Table 137. Oxford Nanopore Technologies Product
Table 138. Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 139. Oxford Nanopore Technologies Recent Development
Table 140. Bio-Rad Laboratories Company Details
Table 141. Bio-Rad Laboratories Business Overview
Table 142. Bio-Rad Laboratories Product
Table 143. Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 144. Bio-Rad Laboratories Recent Development
Table 145. DNASTAR Company Details
Table 146. DNASTAR Business Overview
Table 147. DNASTAR Product
Table 148. DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 149. DNASTAR Recent Development
Table 150. Biomatters Company Details
Table 151. Biomatters Business Overview
Table 152. Biomatters Product
Table 153. Biomatters Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 154. Biomatters Recent Development
Table 155. Partek Company Details
Table 156. Partek Business Overview
Table 157. Partek Product
Table 158. Partek Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 159. Partek Recent Development
Table 160. New England Biolabs Company Details
Table 161. New England Biolabs Business Overview
Table 162. New England Biolabs Product
Table 163. New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 164. New England Biolabs Recent Development
Table 165. Myriad Genetics Company Details
Table 166. Myriad Genetics Business Overview
Table 167. Myriad Genetics Product
Table 168. Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 169. Myriad Genetics Recent Development
Table 170. Macrogen Company Details
Table 171. Macrogen Business Overview
Table 172. Macrogen Product
Table 173. Macrogen Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 174. Macrogen Recent Development
Table 175. GATC Biotech Company Details
Table 176. GATC Biotech Business Overview
Table 177. GATC Biotech Product
Table 178. GATC Biotech Revenue in Next Generation Sequencing (NGS) Business (2015-2020) (Million US$)
Table 179. GATC Biotech Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Sequencing (NGS) Market Share by Type: 2020 VS 2026
Figure 2. Consumables Features
Figure 3. Platforms Features
Figure 4. Services Features
Figure 5. Global Next Generation Sequencing (NGS) Market Share by Application: 2020 VS 2026
Figure 6. Academic & Government Research Institutes Case Studies
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Biotechnology Companies Case Studies
Figure 9. Hospitals & Clinics Case Studies
Figure 10. Next Generation Sequencing (NGS) Report Years Considered
Figure 11. Global Next Generation Sequencing (NGS) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Next Generation Sequencing (NGS) Market Share by Regions: 2020 VS 2026
Figure 13. Global Next Generation Sequencing (NGS) Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Next Generation Sequencing (NGS) Market Share by Players in 2019
Figure 16. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Sequencing (NGS) as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Next Generation Sequencing (NGS) Revenue in 2019
Figure 18. North America Next Generation Sequencing (NGS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Next Generation Sequencing (NGS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Next Generation Sequencing (NGS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Next Generation Sequencing (NGS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Next Generation Sequencing (NGS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Next Generation Sequencing (NGS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Next Generation Sequencing (NGS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
次世代シーケンシング（NGS）データ分析の世界市場（～2026年） North America is home to several well-established organizations of NGS data analysis. A significant number of NGS research projects are being carried out in Canadian universities, which in turn has resulted into huge demand for NGS data analysis, thereby affecting the revenue growth in the region. N…- 臨床腫瘍学次世代シーケンシング（NGS）の世界市場（～2026年） NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations. The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence…
- 次世代シーケンサーの世界市場（～2026年） Next generatio sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The advent of rapid DNA sequencing me…
- メタゲノミクスシーケンスの世界市場（～2026年） Metagenomics is the process of cloning and analyzing the genomes of an organism without culturing them in a community. The major factors driving the growth of the global metagenomics market include technological advancements in DNA sequencing. Moreover, metagenomics is applicable across a broad rang…
- DNAシーケンシング製品の世界市場（～2026年） DNA sequencing is categorized into first-generation, secondand next-generation, and emerging technologies. Emerging DNA sequencing technologies are cost-effective and offer more rapid and accurate results than other generation technologies. These technologies find application in the areas of diagnos…